MAPT and tauopathy: Based on earlier studies indicating that (i) PP2A dysregulation is related to the accumulation of pathological tau, which is a characteristic feature of tauopathies [70] and (ii) alterations in PP2A expression and activity modulate various ECM-associated proteolytic molecules [71], PP2A protein level was initially examined.